BioSpace

Roivant, the 'inveterate drug hunters', enters commercial era with Lisraya

CEO Matt Gline is juggling Roivant Sciences' first solo drug launch and several maturing programs as the hub-and-spoke company sets its sights on a massive turning point into commercial viability.

By BioSpace

1 min read
Roivant, the 'inveterate drug hunters', enters commercial era with Lisraya
Roivant, the 'inveterate drug hunters', enters commercial era with Lisraya

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights